Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Non-Current Liabilities: 2023-2025

  • CG Oncology's Total Non-Current Liabilities was N/A to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year change of. This contributed to the annual value of $14.1 million for FY2023, which is N/A change from last year.
  • CG Oncology's Total Non-Current Liabilities amounted to $38.5 million in Q3 2025, which was up 171.92% from $14.1 million recorded in Q4 2023.
  • In the past 5 years, CG Oncology's Total Non-Current Liabilities registered a high of $38.5 million during Q3 2025, and its lowest value of $14.1 million during Q4 2023.
  • Its 2-year average for Total Non-Current Liabilities is $26.3 million, with a median of $26.3 million in 2023.